|
Volumn 43, Issue 9, 1998, Pages 883-888
|
Minimally invasive coronary surgery at the beginning of the new millennium.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRIN DEGRADATION PRODUCT;
PROTHROMBIN;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
FOLLOW UP;
HEART MUSCLE REVASCULARIZATION;
HEMOSTASIS;
HUMAN;
MINIMALLY INVASIVE SURGERY;
POSTOPERATIVE COMPLICATION;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
THORACOSCOPY;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY ARTERY BYPASS;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
FOLLOW-UP STUDIES;
HEMOSTASIS;
HUMANS;
INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS;
POSTOPERATIVE COMPLICATIONS;
PROSPECTIVE STUDIES;
PROTHROMBIN;
RANDOMIZED CONTROLLED TRIALS;
SURGICAL PROCEDURES, MINIMALLY INVASIVE;
THORACOSCOPY;
TIME FACTORS;
|
EID: 0032150585
PISSN: 03931978
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (43)
|